CLINICAL_TRIALS
trial_result
· 2023-03-16
Clinical Trial Update: Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients With Asthma (Long-Term Follow-Up) [Phase 3]
Summary
Continuation study update for long-term safety of dupilumab in asthma patients from the TRAVERSE trial; completed phase 3 with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2023-03-16